In This Section

Continuing Medical Education (CME)

AACR Virtual Meeting Planner Now AvailableView the Virtual Meeting Platform

This year’s AACR Annual Meeting Educational Program (April 17-18) is jointly provided by Partners for Advancing Clinical Education and the American Association for Cancer Research and brings the latest cancer research from “bench to bedside and back.” The AACR Annual Meeting consists of educational interventions designed to encourage the analysis and discussion of the latest findings in all areas of basic, translational, and clinical cancer research not only among researchers, but also by engaging clinicians in this scientific discourse. The AACR is committed to advancing the ability of clinicians to apply critical aspects of cancer research to the clinical practice of oncology to aid in the detection, diagnosis, treatment, and prevention of cancer. Select sessions within the two-day Educational Program (April 17-18) will be accredited. Individuals must be registered for the meeting by April 22, 2026, to be eligible to request credits for sessions attended in-person or viewed online.

Questions about CME or requests for assistance can be sent to [email protected].

Download the Disclosure Index View the List of CME-Accredited Sessions

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Assess the technological and computational advancements accelerating progress in cancer research and improving early detection and interception, with an ultimate goal to extend patients’ lives and improve their quality of life.
  • Recognize how advances in precision cancer medicine are enhancing patient outcomes by closely monitoring patient response and aiming to reduce side effects.
  • Incorporate the latest research findings regarding therapies and treatment options, including immunotherapy, radiotherapy, and combination therapies, in a variety of cancer types to improve patient outcomes.
  • Evaluate how tumor evolution contributes to resistance to therapy and leverage tumor heterogeneity to develop better strategies for cancer prevention, interception, and treatment.
  • Identify the factors influencing the diagnosis, treatment, and prevention of various cancers in patients from diverse populations and contribute to achieving health equity.
  • Initiate collaborations among physicians, researchers, and clinician-scientists to advance cancer treatment and prevention strategies, and to support survivors.

Disclosure of Conflicts of Interest

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Meeting Planners and Speakers: Disclosure of Financial RelationshipsView the Disclosures

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the American Association for Cancer Research. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 70.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 70.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you must be registered for the meeting by April 22, 2026, and you MUST pass the posttest and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Partners’ Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving Partners permission to use this information/data to report your participation to these Boards JA-PARS.

claiming cme credit

Credit Survey:
All learners requesting Continuing Medical Education (CME) credit must complete the CME Request for Credit Survey via the online planner in order to generate a certificate.

Instructions for Claiming CME/CE Credit and MOC Points:
Click the link below to view the credit claiming instructions for the certificate you need:

Start the Credit Claiming Process

Printing Certificates
Certificates may be printed at the end of the credit-claiming process.

Acknowledgement of commercial support

This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc, and Novartis Pharmaceuticals Corporation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.